Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation

References

• YanYDKimDHSungJHYongCSChoiHGEnhanced oral bioavailability of docetaxel in rats by four consecutive days of pretreatment with curcuminInt J Pharm20103991–211612020727390
   PubMed Web of Science ®Google Scholar
• StraubingerRMBalasubramanianSVPreparation and characterization of taxane-containing lipsomesMethods Enzymol20053919711715721376
   PubMed Web of Science ®Google Scholar
• ten TijeAJVerweijJLoosWJSparreboomAPharmacological effects of formulation vehicles: implications for cancer chemotherapyClin Pharmacokinet200342766568512844327
   PubMed Web of Science ®Google Scholar
• YinYMCuiFDMuCFDocetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluationJ Control Release20091402869419709639
   PubMed Web of Science ®Google Scholar
• LeeEKimHLeeIHJonSIn vivo antitumor effects of chitosan-conjugated docetaxel after oral administrationJ Control Release20091402798519712714
   PubMed Web of Science ®Google Scholar
• MoesJJKoolenSLHuitemaADSchellensJHBeijnenJHNuijenBPharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)Int J Pharm2011420224425021907780
   PubMed Web of Science ®Google Scholar
• YinYChenDQiaoMLuZHuHPreparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentinJ Control Release2006116333734517097180
   PubMed Web of Science ®Google Scholar
• MalamYLoizidouMSeifalianAMLiposomes and nanoparticles: nanosized vehicles for drug delivery in cancerTrends Pharmacol Sci2009301159259919837467
   PubMed Web of Science ®Google Scholar
• MaincentPDevissaguetJPLeVergeRSadoPACouvreurPPreparation and in vivo studies of a new drug delivery system. Nanoparticles of alkylcyanoacrylateAppl Biochem Biotechnol1984102632656524931
   PubMed Web of Science ®Google Scholar
• MaincentPLeVergeRSadoPCouvreurPDevissaguetJPDisposition kinetics and oral bioavailability of vincamine-loaded polyalkylcyanoacrylate nanoparticlesJ Pharm Sci198675109559583795026
   PubMed Web of Science ®Google Scholar
• SakumaSSuzukiNKikuchiHOral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branchesInt J Pharm1997149193106
   Web of Science ®Google Scholar
• YanasarnNSloatBRCuiZNanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxelInt J Pharm2009379117418019524029
   PubMed Web of Science ®Google Scholar
• De MuynckCCuvelierCRemonJPEvaluation of rectal mucosal irritation in rabbits after sub-chronic administration of lecithin-containing suppositoriesJ Pharm Pharmacol199446178798201532
   PubMed Web of Science ®Google Scholar
• FlorenceATNanoparticle uptake by the oral route: fulfilling its potential?Drug Discov Today Technol2005217581
   PubMedGoogle Scholar
• WinKYFengSSEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials200526152713272215585275
   PubMed Web of Science ®Google Scholar
• MusumeciTVenturaCAGiannoneIPLA/PLGA nanoparticles for sustained release of docetaxelInt J Pharm20063251–217217916887303
   PubMed Web of Science ®Google Scholar
• PanditaDAhujaALatherVDevelopment of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxelAAPS Pharm Sci Tech2011122712722
   PubMed Web of Science ®Google Scholar
• SunHChowECLiuSDuYPangKSThe Caco-2 cell monolayer: usefulness and limitationsExpert Opin Drug Metab Toxicol20084439541118433344
   PubMed Web of Science ®Google Scholar
• Ben ReguigaMBonhomme-FaivreLFarinottiRBioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in ratsJ Pharm Pharmacol200759340140817331344
   PubMed Web of Science ®Google Scholar
• LiHZhaoXMaYZhaiGLiLLouHEnhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticlesJ Control Release2009133323824418951932
   PubMed Web of Science ®Google Scholar
• MaYZhaoXLiJShenQThe comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailabilityInt J Nanomedicine2012755957022346351
   PubMed Web of Science ®Google Scholar
• ChoCWFormulation strategy to overcome multi-drug resistance (MDR)Arch Pharm Res201134451151321544714
   PubMed Web of Science ®Google Scholar
• DongXMattinglyCATsengMTDoxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATPCancer Res20096993918392619383919
   PubMed Web of Science ®Google Scholar
• RegevRKatzirHYeheskely-HayonDEytanGDModulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membraneFEBS J2007274236204621417986257
   PubMed Web of Science ®Google Scholar
• GuanMZhuQLLiuYUptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayersInt J Nanomedicine201271921193022605938
   PubMed Web of Science ®Google Scholar
• ConnerSDSchmidSLRegulated portals of entry into the cellNature20034226927374412621426
   PubMed Web of Science ®Google Scholar
• des RieuxAFievezVGarinotMSchneiderYJPreatVNanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approachJ Control Release2006116112717050027
   PubMed Web of Science ®Google Scholar
• YuanHChenJDuYZHuFQZengSZhaoHLStudies on oral absorption of stearic acid SLN by a novel fluorometric methodColloids Surf B Biointerfaces200758215716417446050
   PubMed Web of Science ®Google Scholar
• DucheneDPonchelGBioadhesion of solid oral dosage forms, why and how?Eur J Pharm Biopharm19974411523
   Web of Science ®Google Scholar
• VenkatesanNUchinoKAmagaseKItoYShibataNTakadaKGastro-intestinal patch system for the delivery of erythropoietinJ Control Release20061111–2192616377018
   PubMed Web of Science ®Google Scholar